Isitofu sokugonya se-mpox i-MVA-BN isitofu (oko kukuthi, isitofu sokugonya esiLungisiweyo i-Ankara esenziwa yi-Bavarian Nordic A/S) ibe sisitofu sokuqala se-Mpox ukongezwa kuluhlu oluqinisekisiweyo lwe-WHO. “Imvanex” ligama lezorhwebo lesi sitofu sokugonya.
Ukugunyazwa kwangaphambili kwe-WHO kufuneka kuphuculwe ukufikelela kwisitofu sokugonya i-mpox ngokuthengwa ngokukhawuleza koorhulumente kunye nee-arhente zamazwe ngamazwe kuluntu lwase-Afrika olufuna ukuquka ukuqhambuka kwesifo se-mpox.
Isitofu sokugonya se-Imvanex okanye i-MVA-NA siqulathe intsholongwane yokugonya ehlaziyiweyo ephilayo i-Ankara eyehliswayo okanye yenziwe buthathaka ukuze ingakwazi ukuphindaphinda ngaphakathi emzimbeni.
Ngo-2013, i-Imvanex yamkelwa njengesitofu sokugonya ingqakaqha yi-Arhente yaMayeza yaseYurophu.
Ukusukela nge-22 kaJulayi ka-2022, iye yagunyaziswa phantsi kweemeko ezikhethekileyo yi-Arhente yaMayeza yaseYurophu ukuba isetyenziswe kwi-European Union njengesitofu sokugonya i-Mpox ngokunjalo. E-UK, i-MVA (Imvanex) yamkelwe njengesitofu sokugonya i-mpox kunye ne-smallpox yi-Arhente yoLawulo lweemveliso zamaYeza kunye nezeMpilo (MHRA).
Isitofu sokugonya se-MVA-BN sinconywa kubantu abadala abangaphezu kweminyaka eyi-18 njenge-injection ye-2-dose elawulwa kwiiveki ezi-4 ngaphandle.
I-WHO ikwacebisa ukusetyenziswa kwedosi enye kwiimeko zoqhambuko oluthintelweyo.
Idatha ekhoyo ibonisa ukuba isitofu sokugonya se-MVA-BN sedosi enye esinikwe phambi kokuba sesichengeni siqikelelwa ukuba i-76% isebenza ngempumelelo ekukhuseleni abantu ngokuchasene ne-mpox, kunye neshedyuli ye-2-dose ifezekisa ukusebenza okuqikelelweyo kwe-82%.
Ugonyo emva kokuba sesichengeni alusebenzi kangako kunogonyo lwaphambi kokuba sesichengeni.
Ukuqhambuka kwempox eyandayo e-DR Congo nakwamanye amazwe kwabhengezwa njengengxakeko yezempilo yoluntu kwinkxalabo yehlabathi (PHEIC) nge-14 ka-Agasti ka-2024.
Amazwe angaphezu kwe-120 aqinisekise ngaphezu kwe-103 000 iimeko ze-mpox ukususela ekuqaleni kokuqhambuka kwehlabathi ngo-2022. Ngo-2024 kuphela, kwakukho i-25 237 amatyala akrokrelwayo kwaye aqinisekisiwe kunye nokufa kwe-723 ngenxa yokuqhambuka okuhlukeneyo kumazwe angama-14 oMmandla we-Afrika (ngokusekelwe idatha esuka kwi-8 Septemba 2024).
***
Imithombo:
- Iindaba ze-WHO - WHO iqinisekisa ukuba isitofu sokuqala sokugonya i-mpox. Ipapashwe nge-13 Septemba 2024. Ifumaneka e https://www.who.int/news/item/13-09-2024-who-prequalifies-the-first-vaccine-against-mpox
- EMA. Imvanex – isitofu sokugonya ingqakaqha kunye nemonkeypox (Live Modified Vaccinia Virus Ankara). Igqityelwe ukuhlaziya: 10 Septemba 2024. Ifumaneka e https://www.ema.europa.eu/en/medicines/human/EPAR/imvanex
- Ukukhutshwa kweendaba - I-Bavarian Nordic ifumana uluvo oluhle lwe-CHMP lokubandakanya idatha ye-mpox ye-real-world esebenzayo kwisigunyaziso sentengiso yaseYurophu ye-smallpox kunye nesitofu sokugonya. Ithunyelwe nge-26 kaJulayi 2024. Ifumaneka e https://www.bavarian-nordic.com/media/media/news.aspx?news=6965
***
Amanqaku afanelekileyo:
- Uqhambuko lweMonkeypox (Mpox) lubhengeze iNgxamiseko yeMpilo yoLuntu yeNgxaki yeHlabathi (14 Agasti 2024)
- Izitofu zokugonya i-Monkeypox (Mpox): I-WHO iqalisa inkqubo ye-EUL (10 Agasti 2024)
- Ngaba iMonkeypox iya kuhamba ngendlela yeCorona? (23 ngoJuni 2022)
***
